Insider Cluster (3 insiders) ·Filed Aug 18, 2026

ABCL

AbCellera Biologics Inc.
BULLISH
Impact 5/10
Horizonweeks Processed1mo ago
Insider cluster: 3 insiders, $1.0M total
Actionable Insight ▲ Bullish

The CFO's open-market buy alongside two directors, coming right after a dilutive $200M offering, is a strong vote of confidence in the pipeline. Monitor upcoming ABCL635 Phase 2/3 data readouts and any further insider accumulation. The cluster buys suggest the recent offering-driven selloff may be overdone.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
ABCL ▲ +4.95% at T+20d
LONG call ✓ call won +4.95% · α vs SPY +6.69% · entry $11.12 → $11.67
Next anchor: T+60d in 6w
Latest observation: T+30 -1.89% FF3 residual α
Entry anchored
Aug 18, 02:45 PM ET
via 1-min bar
T+1d
+8.00%
call +8.00% · α +7.79%
$12.01
settled 6w ago
T+5d
+12.41%
call +12.41% · α +12.61%
$12.50
settled 5w ago
T+20d
+4.95%
call +4.95% · α +6.69%
$11.67
settled 16d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Three AbCellera insiders, including the CFO and two directors, purchased a total of ~$975K in open-market shares over a 7-day window following a $200M dilutive offering and positive Phase 2 data for ABCL635. The cluster buys, particularly the CFO's $384K purchase, signal insider confidence in the pipeline despite the recent capital raise dilution. At ~0.03% of market cap, the dollar amount is modest but the C-suite participation and proximity to a catalyst make this a notable bullish signal.

Key Financial Metrics

Direction
buying
Total Value
$975.2K
Insiders
3

Key Facts

  • CFO Andrew Booth bought $384K in open-market shares on 2026-08-14 at $10.32
  • Director Michael R. Hayden bought $481K on 2026-08-12 at $10.37
  • Director John S. Montalbano bought $110K on 2026-08-18 at $11.03
  • Total insider purchases of ~$975K represent ~0.03% of $3.3B market cap
  • Buys occurred within 7 days of a $200M dilutive offering and positive Phase 2 data for ABCL635

Financial Impact

~$975K in insider open-market purchases, ~0.03% of market cap

insider ownership

Risk Factors

  • $200M dilutive offering will significantly increase share count and dilute existing holders
  • Insider purchases are small relative to market cap (~0.03%) and may not move the stock
  • Biotech pipeline risk — ABCL635 Phase 2 data is early and may not replicate in larger trials

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ABCL-1787079683283
12 reports for ABCL
Performance horizon
86% Hit rate 6 of 7 directional calls best @ T+20▲ +127.09%Jul 29, 2026
Filters
Rows
Reports for ABCL — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
Insider Cluster
MIXED ★ 5/10
$10.61 $12.65▲ +19.23%▲ +17.91%$13.74 (+29.50%)
Aug 18, 2026
6w ago
Insider Cluster
BULLISH ★ 5/10
$11.12 $11.67▲ +4.95%▲ +6.69%$13.74 (+23.56%)
Aug 15, 2026
6w ago
Institutional Cluster
BEARISH ★ 6/10
$11.20 $11.41▼ −1.88%▼ −3.85%$13.74 (−22.68%)
Aug 11, 2026
7w ago
424B5
BEARISH ★ 7/10
$10.36 $10.46▼ −1.01%▼ −2.91%$13.74 (−32.69%)
Aug 10, 2026
7w ago
8-K
BULLISH ★ 7/10
$9.34 $11.44▲ +22.48%▲ +23.40%$13.74 (+47.11%)
Jul 29, 2026
9w ago
8-K
BULLISH ★ 6/10
$5.39 $12.24▲ +127.09%▲ +122.07%$13.74 (+154.92%)
Jul 6, 2026
12w ago
3
NEUTRAL ★ 1/10
$7.69 $5.83▼ −24.19%▼ −25.52%$13.74 (+78.67%)
Jul 6, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$7.87 $5.71▼ −27.45%▼ −26.88%$13.74 (+74.59%)
Jun 5, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$5.62 $7.87▲ +40.04%▲ +38.17%$13.74 (+144.48%)
May 11, 2026
20w ago
8-K
BULLISH ★ 7/10
$4.95 $5.09▲ +2.83%▲ +4.56%$13.74 (+177.58%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (37h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 18, 2026